News | November 05, 2006

Philips Introduces MR Simulator, CT Enhancements

Philips announced today at ASTRO the introduction of Panorama 1.0T R/T, a high field open MR simulator, and Tumor Localization (Tumor LOC) version 3.5 for CT, both designed to support department efficiency and provide valuable information during radiation oncology treatment planning.
The Panorama 1.0T is a high field open MR system features whole body diagnostic imaging capabilities, enabling techniques such as diffusion weighted whole body imaging with background body signal suppression (DWIBS) for identifying lesions without exposing the patient to radiation or radioactive isotopes. The open gantry allows for patient scanning in treatment position with immobilization devices or supine inclined for breast imaging. A flat and rigid oncology table-top modeled after the LINAC table and a set of MR-compatible immobilization devices are designed to improve patient alignment.
Tumor LOC, used to localize target volumes for radiation therapy planning, is already available to Philips Brilliance CT Big Bore customers on the console, but with the upgrade to version 3.5 this application will be available for purchase on the Extended Brilliance Workspace (EBW).
The upgrade targets customers with large respiratory correlated workloads as it includes features for viewing respiratory correlated CT datasets and analyzing motion of target and surrounding anatomy. When combined with Remote Reconstruction and Pulmonary Viewer, the 4-D oncology workstation also provides dynamic digitally reconstructed radiographs (DRR) and digitally composited radiographs (DCR) for visualizing respiratory motion and evaluation of multi-phasic volumetric datasets.

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
Videos | Treatment Planning | August 28, 2018
A discussion with...